Indrayani Biotech Ltd

Indrayani Biotech Ltd, a micro-cap player in the Other Agricultural Products sector, touched a fresh 52-week low of Rs.6.1 today, marking a significant decline in its stock price amid ongoing challenges reflected in its financial and market performance.

Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 Nov 2024, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed below represent the stock's current position as of 06 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Indrayani Biotech Ltd has touched a new 52-week low of Rs.7.25 today, marking a significant decline in its share price amid a sustained downward trend. The stock has now recorded losses for three consecutive days, accumulating a negative return of 11.26% over this period, reflecting ongoing pressures within the Other Agricultural Products sector.

Indrayani Biotech Ltd’s stock price declined to a fresh 52-week low of Rs.7.25 today, marking a significant milestone in its ongoing downward trajectory. The stock has been under pressure for several sessions, reflecting persistent challenges within the company and the broader sector.

Indrayani Biotech Ltd’s shares declined to a fresh 52-week low of Rs.7.54 today, marking a significant milestone in the stock’s ongoing downward trajectory. The stock has now underperformed considerably against its sector and benchmark indices over the past year.

Indrayani Biotech Ltd., a micro-cap player in the agricultural products sector, reported a dramatic 75.00% year-on-year decline in consolidated net profit for Q3 FY26, plunging to just ₹0.06 crores from ₹0.24 crores in the corresponding quarter last year. The ₹37.00 crore market capitalisation company's shares have been in freefall, down 62.47% over the past year, with the stock trading at ₹8.07 as of February 27, 2026—a disturbing 65.64% below its 52-week high of ₹23.49.

Indrayani Biotech Ltd has posted a flat financial performance for the quarter ended December 2025, signalling a stabilisation after a period of negative trends. While net sales surged impressively by over 100%, key profitability and operational metrics reveal a complex picture, with margin pressures and liquidity concerns persisting. The company’s recent upgrade in financial trend score from -9 to -2 reflects this nuanced recovery, yet challenges remain in inventory and debtor management alongside elevated debt levels.

Indrayani Biotech Ltd’s stock price declined to a fresh 52-week low of Rs.7.73 today, marking a significant milestone in its ongoing downward trajectory. The stock has been under pressure for the past six trading sessions, cumulatively losing 6.09% in value during this period, reflecting persistent challenges within the company’s financial and operational metrics.

Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 Nov 2024, but the analysis below reflects the stock’s current position as of 18 February 2026, incorporating the latest fundamentals, returns, and financial metrics available today.

Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 Nov 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 February 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Indrayani Biotech Ltd’s stock declined sharply to a fresh 52-week low of Rs.7.99 on 5 Feb 2026, marking a significant downturn amid persistent financial headwinds and sectoral pressures. The stock’s fall comes despite a modest outperformance relative to its sector on the day, reflecting ongoing challenges in the company’s performance and valuation metrics.

Indrayani Biotech Ltd’s stock price declined to a fresh 52-week low of Rs.8.5 today, marking a significant milestone in its ongoing downward trajectory. The stock has underperformed its sector and benchmark indices, reflecting persistent financial pressures and subdued market sentiment.

Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 26 January 2026, providing investors with the latest insights into its performance and prospects.

Indrayani Biotech Ltd’s shares touched a fresh 52-week low of Rs.8.56 today, marking a significant decline amid ongoing financial pressures and subdued market sentiment. This new low reflects a continuation of the stock’s downward trajectory over the past year, with the company’s performance lagging notably behind broader market indices.

Indrayani Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 November 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Indrayani Biotech Ltd, a player in the Other Agricultural Products sector, recorded a fresh 52-week low of Rs.9.42 today, marking a significant decline in its stock price amid persistent financial headwinds and underwhelming market performance.

Indrayani Biotech Ltd, a player in the Other Agricultural Products sector, has touched a new 52-week low of Rs.9.6 today, marking a significant decline in its stock price amid ongoing downward momentum and sectoral pressures.